Navigation Links
'Half-Match' Marrow Transplants Help Some With Sickle Cell
Date:9/21/2012

By Alan Mozes
HealthDay Reporter

FRIDAY, Sept. 21 (HealthDay News) -- In what might one day prove to be a breakthrough for those suffering from sickle cell anemia, new research suggests that bone marrow transplants based on partially matched donors can, in some cases, turn out as well for patients as fully matched transplants.

But, the finding is based on a very small study involving just 17 patients, and was described as "preliminary" in nature.

Still, with fully matched donors in drastically short supply, the notion that so-called "half-matched" transplants might also work raises the possibility that many more patients could avail themselves of a treatment for what can be an extremely painful, debilitating and ultimately fatal illness.

"We're trying to reformat the blood system and give patients new blood cells to replace the diseased ones, much like you would replace a computer's circuitry with an entirely new hard drive," study author Dr. Robert Brodsky, director of the division of hematology at Johns Hopkins and the Johns Hopkins Family Professor of Medicine and Oncology in Baltimore, said in a university news release.

"[But] while bone marrow transplants have long been known to cure sickle cell disease, only a small percentage of patients have fully matched eligible donors," he added.

Brodsky and his colleagues discussed the donor dilemma and their efforts to broaden transplant options in the Sept. 6 online edition of the journal Blood.

Roughly 100,000 Americans live with sickle cell anemia, a genetic disorder that impedes the normal workings of hemoglobin molecules responsible for transporting oxygen within red blood cells. The stiffening and misshaping of such cells into the telltale form of a "sickle" ultimately leads to cell clumping. In the end, oxygen delivery to organs and tissues shuts down.

As the illness progresses, patients typically struggle with excruciating pain, along with a risk complications, including kidney failure, stroke, lung disease and blood clots. Many die of the disease before the age of 50.

Treatment is often centered around the use of narcotics for pain control, along with frequent blood transfusions and hospitalizations.

The good news: bone marrow transplants involving fully matched tissue donors have shown the potential to effect a cure in some patients.

The bad news: the vast majority of patients are black (with about one in every 400 blacks struck by the disease) and national donor registries are limited, leaving many to wait in vain for a donor match.

Brodsky and his team performed bone marrow transplants involving both fully matched donors (three cases) and half-matched donors (14 cases), among patients between 15 and 46 years of age.

Both full and partial donor matches were drawn from family members such as parents, children and/or siblings. And all patients underwent a comparatively "gentle" pre-procedure prep regimen of immuno-suppression, chemotherapy and radiation treatment, the study authors said.

The result: 11 of the 17 transplants were deemed "successful." And of these 11 patients, eight had undergone half-matched operations.

The study authors said there were no fatalities. They concluded that the half-matched approach appeared to produce a success rate greater than 50 percent.

Dr. Zora Rogers, clinical director of the General Hematology Program at the Children's Medical Center in Dallas, said that while the findings are "encouraging," they should be interpreted with caution.

"First of all," she said, "it's important to recognize that this half-matched procedure performed predominantly among adults was not as good as a fully matched transplant performed among children would be, where the cure rate exceeds 90 percent. In fact, when you look at the 11 patients they say got better, six of them, if you will, were really 'cured' of their disease, while the other five of them remained a mixture of someone with the disease and without."

"But more importantly," Rogers added, "I would also point out that what a success rate of a little bit over 50 percent means is that you could go through this very big deal transplant, put your life at risk, and have it fail about half the time. Now, sickle cell is a horrible disease. Don't get me wrong. But unlike in leukemia or other malignancies where a transplant is your only hope, with sickle cell it's just an option. So, for patients who wish to pursue a cure this may expand their choices. But they need to consider this information carefully."

More information

For more on sickle cell anemia, visit the U.S. National Library of Medicine.

SOURCE: Sept. 20, 2012, news release, Johns Hopkins, Baltimore


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Half-match bone marrow transplants wipe out sickle cell disease in selected patients
2. Fertilizing bone marrow helps answer why some cancers spread to bones
3. Markey receives $6.25 million to study deadly blood and bone marrow disease
4. HIV Drug May Prevent Bone Marrow Transplant Complication
5. HIV drug reduces graft-vs.-host disease in bone marrow transplant patients, Penn study shows
6. Clinical trial seeks to cure advanced Crohns disease using bone marrow transplant
7. Bone marrow transplant eliminates signs of HIV infection
8. HIV Undetectable in 2 Men After Bone Marrow Transplants: Study
9. New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
10. Lack of sleep affects bone health and bone marrow activity
11. First, Second Kidney Transplants Have Similar Success: Study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
'Half-Match' Marrow Transplants Help Some With Sickle Cell
(Date:6/28/2017)... ... June 28, 2017 , ... Continually at the forefront of ... Drops™ have received the Non-GMO Project Verified seal. All five flavors of the ... only third-party verification for non-GMO foods and products in North America. , Available ...
(Date:6/28/2017)... VA (PRWEB) , ... June 28, 2017 , ... Guide ...      , No matter on which side of the Atlantic devicemakers do ... device regulations they have to follow. , In addition to the full text of ...
(Date:6/28/2017)... ... , ... Anyone with a remote control has seen the never-ending twists on the house flipping ... get rich in no time. But what about the buyers of the flipper's flip. ... of a flipped house. An email recently sent to Gary Case said, “Just closed ...
(Date:6/28/2017)... ... ... David B. Sosin, a founding partner at the law firm Sosin, Arnold & ... for the Illinois State Bar Association , in accordance with the organization’s rules of ... following a state-wide election and served in that capacity for the past year prior to ...
(Date:6/28/2017)... ... , ... American Farmer proudly announces the participation of Pure Line Seeds, Inc ... to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET on RFD-TV. , ... seed. As demand grew, the small company located in Moscow, Idaho extended its sales ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... Md. , June 7, 2017  Novavax, Inc., (Nasdaq: ... second of two Phase 2 trials of its RSV F ... of child bearing age have been published in the journal ... publication have been shared in prior scientific conferences). The Company ... in April 2014. Novavax is developing the RSV F Vaccine ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: